These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

364 related items for PubMed ID: 11557788

  • 1. Factors that influence the measurement of prostate cancer DNA ploidy and proliferation in paraffin embedded tissue evaluated by flow cytometry.
    So MJ, Cheville JC, Katzmann JA, Riehle DL, Lohse CM, Pankratz VS, Sebo TJ.
    Mod Pathol; 2001 Sep; 14(9):906-12. PubMed ID: 11557788
    [Abstract] [Full Text] [Related]

  • 2. DNA ploidy and proliferation heterogeneity in human prostate cancers.
    Shankey TV, Jin JK, Dougherty S, Flanigan RC, Graham S, Pyle JM.
    Cytometry; 1995 Sep 01; 21(1):30-9. PubMed ID: 8529468
    [Abstract] [Full Text] [Related]

  • 3. A DNA cytometric proliferation index improves the value of the DNA ploidy pattern as a prognosticating tool in patients with carcinoma of the prostate.
    Ahlgren G, Lindholm K, Falkmer U, Abrahamsson PA.
    Urology; 1997 Sep 01; 50(3):379-84. PubMed ID: 9301701
    [Abstract] [Full Text] [Related]

  • 4. Conventional assessment of needle biopsy specimens is more useful than digital image analysis of proliferation and DNA ploidy in prediction of positive surgical margins at radical prostatectomy.
    Sengupta S, Cheville JC, Lohse CM, Zincke H, Myers RP, Riehle DL, Pankratz VS, Blute ML, Sebo TJ.
    Urology; 2006 Jul 01; 68(1):94-8. PubMed ID: 16844452
    [Abstract] [Full Text] [Related]

  • 5. [Flow cytometry in prostate cancer. Evaluation of its feasibility for biopsy specimens and correlation with grading].
    Ferrara G, Monaco R, Capasso A, Bellomo PF, Fruttero A, Pugno F, Nappi O, Ruà S.
    Pathologica; 1998 Feb 01; 90(1):14-9. PubMed ID: 9628974
    [Abstract] [Full Text] [Related]

  • 6. Metaphase cytogenetics and DNA flow cytometry with analysis of S-phase fraction in prostate cancer: influence on prognosis.
    Bratt O, Anderson H, Bak-Jensen E, Baldetorp B, Lundgren R.
    Urology; 1996 Feb 01; 47(2):218-24. PubMed ID: 8607238
    [Abstract] [Full Text] [Related]

  • 7. Prognostic value of DNA ploidy, bcl-2 and p53 in localized prostate adenocarcinoma incidentally discovered at transurethral prostatectomy.
    Abaza R, Diaz LK, Laskin WB, Pins MR.
    J Urol; 2006 Dec 01; 176(6 Pt 1):2701-5. PubMed ID: 17085199
    [Abstract] [Full Text] [Related]

  • 8. Correlation of protein expression, Gleason score and DNA ploidy in prostate cancer.
    Lexander H, Palmberg C, Hellman U, Auer G, Hellström M, Franzén B, Jörnvall H, Egevad L.
    Proteomics; 2006 Aug 01; 6(15):4370-80. PubMed ID: 16888723
    [Abstract] [Full Text] [Related]

  • 9. Flow cytometry in prostate cancer: histological and clinical correlation.
    de Leval L, Waltregny D, Greimers R, Boniver J.
    Acta Urol Belg; 1994 Apr 01; 62(1):37-43. PubMed ID: 8197928
    [Abstract] [Full Text] [Related]

  • 10. Microvessel density as a molecular marker for identifying high-grade prostatic intraepithelial neoplasia precursors to prostate cancer.
    Sinha AA, Quast BJ, Reddy PK, Lall V, Wilson MJ, Qian J, Bostwick DG.
    Exp Mol Pathol; 2004 Oct 01; 77(2):153-9. PubMed ID: 15351240
    [Abstract] [Full Text] [Related]

  • 11. Caveats in the estimation of DNA-ploidy in paraffin embedded specimens of primary prostate cancer and lymph node metastases by flow and image cytometry.
    Berner A, Danielsen HE, Juul NO, Juul ME, Pettersen EO, Reith A, Nesland JM, Fosså SD.
    Anal Cell Pathol; 1993 Nov 01; 5(6):339-52. PubMed ID: 8305330
    [Abstract] [Full Text] [Related]

  • 12. Relationship between DNA ploidy, glandular differentiation, and tumor spread in human prostate cancer.
    Frankfurt OS, Chin JL, Englander LS, Greco WR, Pontes JE, Rustum YM.
    Cancer Res; 1985 Mar 01; 45(3):1418-23. PubMed ID: 3971384
    [Abstract] [Full Text] [Related]

  • 13. Multivariate analysis of the prognostic significance of DNA-ploidy and S-phase fraction in ovarian cancer determined by flow cytometry following detection of cytokeratin-labeled tumor cells.
    Kimmig R, Wimberger P, Hillemanns P, Kapsner T, Caspari C, Hepp H.
    Gynecol Oncol; 2002 Jan 01; 84(1):21-31. PubMed ID: 11748971
    [Abstract] [Full Text] [Related]

  • 14. Do Ki67, S-phase, S + G2M and DNA ploidy, evaluated by flow cytometry, reveal locoregional metastasis in oral cavity and oropharynx carcinomas?
    Tirelli G, Sidari L, Giacomarra V, Papanikolla L, Sasso F, Russolo M, Melato M.
    Oncol Rep; 2002 Jan 01; 9(3):575-80. PubMed ID: 11956630
    [Abstract] [Full Text] [Related]

  • 15. Potential markers of prostate cancer aggressiveness detected by fluorescence in situ hybridization in needle biopsies.
    Takahashi S, Qian J, Brown JA, Alcaraz A, Bostwick DG, Lieber MM, Jenkins RB.
    Cancer Res; 1994 Jul 01; 54(13):3574-9. PubMed ID: 8012984
    [Abstract] [Full Text] [Related]

  • 16. Comparison of flow and image cytometry for DNA content analysis of fresh and formalin-fixed, paraffin-embedded tissue in breast carcinoma.
    Chen TL, Luo I, Mikhail N, Rasková J, Raska K.
    Cytometry; 1995 Sep 15; 22(3):181-9. PubMed ID: 8556949
    [Abstract] [Full Text] [Related]

  • 17. p53 expression, proliferation marker Ki-S5, DNA content and serum PSA: possible biopotential markers in human prostatic cancer.
    Papadopoulos I, Rudolph P, Wirth B, Weichert-Jacobsen K.
    Urology; 1996 Aug 15; 48(2):261-8. PubMed ID: 8753738
    [Abstract] [Full Text] [Related]

  • 18. [Comparison between nuclear DNA and histologic grade of prostatic carcinoma].
    Zattoni F, Prayer Galetti T, Vianello F, Bertoldin R, Panozzo M, Blandamura S, Costantin G.
    J Urol (Paris); 1992 Aug 15; 98(4):192-5. PubMed ID: 1284300
    [Abstract] [Full Text] [Related]

  • 19. DNA image cytometry of prostatic carcinoma: a comparison of needle core biopsy and subsequent prostatectomy specimens.
    Leung CS, Zbieranowski I, Demers J, Murray D.
    Mod Pathol; 1994 Feb 15; 7(2):195-9. PubMed ID: 8008743
    [Abstract] [Full Text] [Related]

  • 20. Flow cytometry vs. Ki67 labelling index in breast cancer: a prospective evaluation of 181 cases.
    Martínez-Arribas F, Núñez MJ, Piqueras V, Lucas AR, Sánchez J, Tejerina A, Schneider J.
    Anticancer Res; 2002 Feb 15; 22(1A):295-8. PubMed ID: 12017306
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.